Article
type: Class

2019
type: Class

Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

Conference Paper
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-17T08:05:33
publisher: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).
label: RDF description of Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC). - http://research.umh.es/vivo/pub/comunicacion/208943

Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).
type: 2019
type: Entity
included: Optimización Biofarmacéutica y disolución biopredictiva 2019
related by: Autor:152123-Comunicación:208943
RO_0002353: XIV CONGRESO DE LA SOCIEDAD ESPAÑOLA DE FARMACIA INDUSTRIAL Y GALENICA
date time value: 208943 pubdate
most specific type: Conference Paper
type: Anualidad
type: Continuant
related by: AutorExt:323971_2019-Comunicación:208943
related by: Autor:179995-Comunicación:208943
ARG_2000028: 208943 vcard
type: Thing
related by: AutorExt:323970_2019-Comunicación:208943
related by: Autor:152399-Comunicación:208943
related by: Autor:160261-Comunicación:208943
type: Information Content Entity
included: Ingeniería 2019
type: Generically Dependent Continuant
type: Conference Paper
most specific type: 2019
type: Congress communication
type: Article
type: Document
most specific type: Congress communication

Optimización Biofarmacéutica y disolución biopredictiva 2019
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
type: 2019
includes: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

Autor:152123-Comunicación:208943
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

XIV CONGRESO DE LA SOCIEDAD ESPAÑOLA DE FARMACIA INDUSTRIAL Y GALENICA
type: Anualidad
RO_0002234: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).
type: Entity
type: Conference
type: Thing
type: 2019
type: BFO_0000015
type: Event
type: BFO_0000003

AutorExt:323971_2019-Comunicación:208943
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

Autor:179995-Comunicación:208943
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

AutorExt:323970_2019-Comunicación:208943
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

Autor:152399-Comunicación:208943
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

Autor:160261-Comunicación:208943
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).

Ingeniería 2019
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
type: 2019
includes: Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC).